HCAL
AUPH icon

HURRICANE CAPITAL ADVISORS LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
8,110
+1,637
+25% +$26.2K 0.03% 471
2026
Q1 		$95.9K Buy
6,473
+1,509
+30% +$22.1K 0.03% 407
2025
Q4 		$79.2K Sell
4,964
-375
-7% -$5.32K 0.03% 460
2025
Q3 		$59K Buy
+5,339
New +$58.3K 0.01% 539

Other funds holding AUPH

Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's AUPH Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC increased its Aurinia Pharmaceuticals (AUPH) stake by 25% in Q2 2026, buying an estimated $26.2K and bringing the position to 8,110 shares worth $138K. The position accounts for 0.03% of the portfolio, ranked #471.

HURRICANE CAPITAL ADVISORS LLC first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. 285 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 8,110 shares of Aurinia Pharmaceuticals worth $138K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC bought 1,637 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $26.2K.
  • Aurinia Pharmaceuticals made up 0.03% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #471 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 285 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.